TRPM2 exhibited similar results; higher expression of TRPM2 had been proven in various cancers including breast cancer, prostate cancer, pancreatic cancer, leukemia, and neuroblastoma [44]. This evidence concerns the gene TRPM2 and prostate carcinoma.